Modulation of Toxin-Antitoxin System Rnl AB Type II in Phage-Resistant Gammaproteobacteria Surviving Photodynamic Treatment by Hosseini, Nava et al.
Please cite this article as follows: Hosseini N, Pourhajibagher M, Chiniforush N, Hosseinkhan N, Rezaie P, Bahador A. Modulation 




Modulation of Toxin-Antitoxin System Rnl AB Type II 
in Phage-Resistant Gammaproteobacteria Surviving 
Photodynamic Treatment    
Nava Hosseini1†, Maryam Pourhajibagher2†, Nasim Chiniforush3†, Nazanin Hosseinkhan4, Parizad Rezaie1, 
Abbas Bahador5*
1Department of Microbiology, Faculty of Biology, College of Science, University of Tehran, Tehran, Iran
2Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran
3Laser Research Center of Dentistry (LRCD), Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran
4Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology 
and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5Dental Implant Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran
Abstract
Type II toxin-antitoxin (TA) systems are the particular type of TA modules which take part in 
different kinds of cellular actions, such as biofilm formation, persistence, stress endurance, 
defense of the bacterial cell against multiple phage attacks, plasmid maintenance, and 
programmed cell death in favor of bacterial population. Although several bioinformatics 
and Pet lab studies have already been conducted to understand the functionality of already 
discovered TA systems, still, more work in this area is required. Rnl AB type II TA module, which 
is composed of RnlA toxin and RnlB antitoxin, is a newly discovered type II TA module which 
takes part in the defense mechanism against T4 bacteriophage attack in Escherichia coli K-12 
strain MH1 that has not been widely studied in other bacteria. Because of the significant role 
of class Gammaproteobacteriacea in a diverse range of health problems, we chose here to 
focus on this class to survey the presence of the Rnl AB TA module. For better categorization 
and description of the distribution of this module in this class of bacteria, the corresponding 
phylogenetic trees are illustrated here. Neighbor-joining and the maximum parsimony methods 
were used in this study to take a look at the distribution of domains present in RnlA and RnlB 
proteins, among members of Gammaproteobacteria. Also, the possible roles of photodynamic 
therapy (PDT) in providing a substrate for better phage therapy are herein discussed.
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Introduction
The procedure employed by bacterial cells when 
encountering stressful situations is to reduce the rate of 
stable RNAs production by the alarmones, like (p)ppGpp, 
so it is logical to be equipped with strategies which 
can regulate the synthesis of DNA and protein.1 These 
modules are known as toxin-antitoxin (TA) systems, 
which usually are composed of 2 elements; the stable 
toxin, and the liable antitoxin, however, hybrid systems 
exist too.2,3 Based on this fact, the nature of the antitoxin 
can be of protein or antisense-RNA and, according to 
the recent categorization of these systems, there are six 
groups of TA modules, including the following:
Type I: This system is composed of 2 parts: the toxin 
component, which is a small hydrophobic protein; and 
an antitoxin part, which is either a cis-encoded antisense-
RNA or a trans-encoded sRNA. The function of the 
toxin is to destroy the cell membrane, which leads to 
the inhibition of ATP synthesis as well as to important 
processes of cell life, like replication, transcription, and 
translation which result in cell death. The function of 
the antitoxin is to prevent this course by inhibiting toxin 
mRNA translation and preventing toxin production at 
first step (this prevention can occur in different ways). 
Examples of type 1 TA modules are found in different 
gram-positive and gram-negative bacteria; the first type 
1 TA module, introduced in 1986 by Ken and Gerdes, 
is the Hok (host killing)-Sok (suppressor of killing) 
system on locus Par B of low-copy-number plasmid 
R1 of Escherichia coli, which is specified to take part in 
plasmid maintenance. Deficiency of plasmid in newborn 
daughter cells results in their cell death, which denotes the 
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phenomenon of “post-segregational killing”. According 
to this phenomenon, the cells which do not acquire the 
plasmid carrying TA module are condemned to die. The 
reason is a pause that occurs in transcription, so after this, 
the ratio of a remaining toxin to antitoxin starts to be 
unequal and toxin reaches higher concentration. It is the 
unstable structure of antitoxin that leads to its destruction 
by cellular proteases like RNase III and in this way, free 
toxins start to manage their ruining effects on cells. Also, 
one example of type 1 TA module in Gram-positive 
bacteria is the fstI-RNAII system.4-8
Type II: This type of system is the best described TA 
module to date. There have been many bioinformatical 
and experimental researches in this area. The first 
described type II TA module, Ccd AB, with plasmid 
maintenance performance discovered by Ogura and 
Hiraga in 1983 on Mini-F plasmid of E. coli K-12, and 
the other was on the Sok-Hok system, resident at Par 
B locus of E. coli K-12 strain, introduced by Bravo, 
Torrontegui, and Diaz, which both take part in plasmid 
stability. In general, these systems are comprised of 2 
protein elements, in which the antitoxin part inhibits 
the function of the toxin by interacting directly with the 
toxin. Whenever the bacterial cell is confronted with 
rough stressful conditions, the antitoxin protein is being 
degraded by proteases like Lon,9 or different kinds of 
CLPs found in cytoplasmic environments; the reason is 
the vulnerable structure of antitoxin. Their operons reside 
whether in plasmid or chromosome and although the 
proper and ultimate function of chromosomal type II TA 
systems is not well described,10 according to the reports 
of different works, we can attribute some tasks to them, 
of which the predominant one is stress response in which 
the toxin part is activated during stressful conditions.11-13 
As will be mentioned further on, the functional character 
of type II toxin, after facing stressful conditions, is often 
to induce bacteriostatic term in the cells, which helps the 
bacteria to stop metabolism to withstand inappropriate 
environments, or which leads the bacteria to cell death 
in which the bacteria sacrifice itself for others’ sake.14,15 
Different type II TA modules play important diverse 
roles, like Mqs RA involved in biofilm formation in E. 
coli,16 Hig BA influencing different virulence factors in 
Pseudomonas aeruginosa,17 and YefM-YoeB and some 
others helping bacteria to survive inside of the host cells.18 
Hip A toxin in E. coli mediates the persister cell formation19 
(although the type I TA module contributes in persister 
cell formation too),20 or involvement of systems like Maz 
EF system in defense against bacteriophage attack, etc.21 
All are recognized as the importance of this particular TA 
system.
Type III: Tox IN is the first described type III TA module, 
discovered in Pectobacterium atrosepticum by Fineran et al 
in 2009, with protein toxin and antisense-RNA antitoxin-
like type I system, but the difference is that antitoxin 
shapes a pseudoknot and interacts directly with protein 
toxin, which has endoribonuclease activity, and through 
this way the plastidic type III TA modules plays a role in 
defense against phage attack.22
Type IV: Both toxin and antitoxin components are 
protein-like type II, but the difference is in the procedure 
of performance. In this type, there is a competition 
between toxin and antitoxin, in which they never interact 
directly with each other but struggle on the same cellular 
aim. In other words, it is like antitoxin tries to fortify the 
cellular target, which toxin tries to demolish. An example 
of this system is the Yee UV system, which is identified 
in E. coli.23
Type V: In this type of TA module, the result of toxin 
translation is the destruction of the cell membrane (like 
type I TA systems). The function of type V antitoxin is 
cleavage of the toxin mRNA. An example is the Gho ST 
system in E. coli.24
Type VI: Newly identified, present in Caulobacter 
crescentus, this is an interesting module because here, 
instead of antitoxin, the toxin part is being degraded by 
the protease, and the attractive aspect of this is that the 
antitoxin helps the protease to degrade the toxin. Sok AB 
is an example of this type of system where Soc B toxin 
ruins the replication process.
So, the overall functions of TA systems researched before 
now, plasmidic or chromosomally, are to maintain the 
survival of the bacterial cells during stressful conditions, 
like the presence of antibiotics, enduring starvation, 
oxidative stress, pH or temperature, the stress of immune 
system response, and bacteriophage attack. These systems 
that have been categorized into 12 families are present as 
potential weapons in the stability of pathogenic bacteria 
against intra-phagosomal nutrient starvation, autophagy 
response, lysosomal enzymes, oxidative/nitrosative burst, 
acidic pH in phagosomes on the intracellular environment, 
and antibody/complement attack and phagocyte attack in 
tissues and extracellular matrix.25
Importance of Type II Toxin-Antitoxin Modules
As mentioned earlier, one of the specific types of TA 
modules is the type II system, which is important in 
virulence and in the ability of transposition by HGT, 
and it is capable of regulation of bacterial physiology 
during inappropriate, improper stressful environmental 
situations. Bioinformatics researches have proved that 
they are widely distributed among bacteria and archaea.3
RnlA-RnlB TA Module as an Interesting Type II TA 
System
In general, there are different kinds of RNase in E. coli, 
(e.g., RNase G, or RNase P, or RNase Z), in which every 
enzyme makes a contribution in cleavage to a special 
region, but their responsibilities have been proved to be 
limited, and they have evolved to perform their functions 
in different circumstances.26,27 RNase LS is also one of 
the bacterial enzymes which participates in cleavage of 
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mRNAs of phage T4 when the bacteria have been attacked 
by an intruder phage.28 Not only does this RNase tend to 
cleave mRNAs of T4 phages, but also it has other functions 
which are not as bold as this specific duty, e.g., RNase LS 
takes part in total mRNA turnover of bacterial cells and 
also contributes to the metabolism of small RNAs. In 
some aspects, RNase LS is almost an equivalent purport 
of the protein RnlA (a protein with 357 amino acid [aa] 
lengths and a weight of 40 kD) 27 This is because it has 
been proved that RnlA protein has a role in RNase LS 
functionality for 2 reasons: firstly, it has endoribonuclease 
activity (they both cleave the socRNA almost at the 
same region); and secondly, whenever a phagic protein 
discriminates messages for degradation of dmd-binding 
domain (Dmd) (73), which is a protein that helps the 
phage to propagate after infection, and its expression 
increases highly after phage attack, a protein with length 
of 60 aa and weight of 7 kD comes around, cleaving both 
the RNase LS and RnlA nearly at the same region of them, 
and in fact halts both the RnlA and RNase LS activities. 
So, we can conclude that the action of Dmd is similar to 
the antitoxin component in common type II TA systems 
(an appurtenance that terminates the endoribonuclease 
activity) which neutralize the toxin RnlA. After the 
survey of DNA sequence of E. coli, researchers noticed 
that the ORFs of rnlA (a gene which encodes RNase LS 
or RnlA) and rnlB (a gene that encodes RnlB), are settled 
in a way like they are forming an operon and there is a 
7 bp overlapping section between them, so they seem to 
be transcribed together and these 2 genes are likely to 
form an operon.29 As mentioned previously, the rnlB gene 
encodes a protein, RnlB (previously described as yfjO), 
which acts like phagic DMD and is able to suppress RnlA 
toxin.
The reasons for them being considered as TA modules are 
as follows30:
1. Endoribonuclease activity of RnlA and neutralization 
by a protein component (RnlB) are encoded from the 
same operon (like other type II TA systems).
2. The structure of RnlB is vulnerable, compared to RnlA, 
and can be easily degraded by cellular proteases like Lon 
or ClpXP. This degradation helps RnlA to be activated 
whenever T4 phage infection occurs.
3. Whenever RnlB protein is absent, a large number of 
mRNAs in E. coli are being demolished by RnlA.
4. There is an interaction between RnlA and RnlB 
components during the stability of bacterial cells.
5. In general, type 2 mRNA interferases usually preform 
their translation inhibition by cleavage of mRNAs, and 
they attend to this task in 2 different ways: ribosome-
dependent (where toxin cleaves mRNAs at ribosomal 
A site by association directly with this part) like Hig B 
toxin; and ribosome-independent, like Mqs R toxin. But a 
toxin like RnlA has this ability to cleave mRNAs both in a 
ribosome-dependent and ribosome-independent manner 
during the translation process.
It should be mentioned that there are some exceptional 
instances regarding this TA module, which are discussed 
below:
1. In spite of the organization of typical type 2 TA operons, 
the rnlA and rnlB ORFs are located in an opposite way 
(rnlB is placed immediately at the downstream part of 
rnlA), like Mqa RA or Hic AB systems.
2.  Another exception to this system is the structure of 
RnlA toxin, in comparison with the other common 
toxins. The architecture of this toxin is unique and it is 
composed of three domains usually not found in other 
toxins: NTD (N-terminal domain); NRD (N-repeated 
domain); and DBD (dmd-binding domain), which are 
separately organized domains. The helix, located at the 
C-terminus of domain DBD, is the only part of the helix 
which interacts with dmd phagic protein and causes 
RnlA to be suppressed. Practically, DBD domain is the 
part responsible for recognition and inhibition of phagic 
dmd antitoxin; also, it is a specific domain for RnlA 
dimerization, dmd attachment, cellular localization, and 
toxicity.31 
Gammaproteobacteria as a Significant Pathogenic Class
A great number of significant and known pathogenic 
bacteria involved in different human, animal, and plant 
diseases are related to the class Gammaproteobacteria. 
So, as the deficiency of this factor can alter the process 
of virulence, it is worth to investigate TA systems of the 
pathogenic bacteria of this important class. As we know, 
this class is composed of orders in which we would 
emphasize the members which have been searched and 
surveyed for the presence of type 2 TA systems and, in 
some cases, the functionalities of the modules have been 
investigated.32
Although most of the type II TA systems are composed of 
2 parts toxin, and antitoxin, it has to be mentioned that 
some of these pathogenic bacteria contain hybrid systems 
of TA modules.33,34
Shigella flexneri, which belongs to the family 
Enterobacteriaceae and induces diarrhea in humans, 
contains Vap BC, Maz EF, Rel BE, and Par DE type II TA 
modules.35,36
Salmonella typhimurium, which is also a member of 
this family and is a pathogen of humans because of 
the gastrointestinal inflammation that the bacteria 
induce and which eventually causes typhoid fever, is 
comprised of Phd-Doc, Rel BE, Vap BC, and Hig BA TA 
systems.37,38  Klebsiella penumoniae, another member of 
Enterobacteriaceae family, from Klebsiella genus, which 
causes ruining problems in human and animal lungs and 
which is problematic in nosocomial infections, contains 
the Rel BE type 2 TA system both in chromosome and 
plasmid locations.39
Some strains of E. coli, for example, O157 which 
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causes hemorrhagic diarrhea, and K-12, which is used 
extensively in molecular biology, have been broadly 
studied and a lot of TA systems have been reported in 
them up to now, including Maz EF, Par DE, Rel BE, Hig 
BA, Hic BA, and Ccd AB, Mqs RA, Hip AB, YafQ-YoeB, 
PrlF-YhaV, YefM-YoeB, Hip AB, Chp BIK, DinJ-YafQ, 
Vap BC, Kis-Kid, Phd-Doc, Cpt IN, YafW-YkfL, Yaf NO, 
YfjZ-YpjF, and Rnl AB (which our focus is concentrated 
on in this system). Of course, other strains of this species 
have been investigated for the presence of TA modules, 
e.g., the type II systems of Pem KI, Srn BC, Vag CD, Par 
AB, Psi AB, Pas TI, and TomB-Hha.40-42
Yersinia pestis, which is also a member of this family 
(Enterobacteriaceae) and mainly is the “agent of plague” 
in patients, contains these functional TA modules, such 
as Hig BA, rel BE, Phd-Doc module and Hic AB.43,44 
For the last example of a member of Enterobacteriaceae 
family, Proteus vulgaris should be mentioned. This 
opportunistic pathogen, which is especially involved in 
wound infections, has a widespread Hig BA type II TA 
system.45
Haemophilus influenza, involved in an extended range 
of infections including localized and invasive ones and 
belonging to the Pasteurellaceae family, processes vap-
type systems.46,47 The TA systems of type II modules of 
Vibrio pathogens, the members of family Vibrionaceae, 
are as follows: 
Vibrio cholera has five different modules of TA systems 
such as Par DE, Rel BE, Ccd AB, Hig BA, and Hip 
BA.48 V. parahaemolyticus, the bacteria which causes 
gastrointestinal problems in humans and another 
member of this group, contains type II systems of Par DE, 
Rel BE, Ccd AB, and Hip BA,49 and V. vulnificus, which 
contains Par DE, Rel BE, Ccd AB, Hic BA, and Hip BA 
systems, causes septicemia.50
Another important family, which belongs to the order 
Pseudomonadales, is Pseudomonadaceae. A very 
important opportunistic pathogen exists in this family, P. 
aeruginosa, and its association with especially hospital-
acquired infections has been proved. According to 
researches which have been done regarding TA systems 
of this pathogen, it possesses YefM-yoeB, Maz EF, Hig 
BA, Rel BE, Par DE, Par AB, Pas TI, Tox1-Tox2, T-AT1-2, 
Gra TA, Vap-type system, and Hha-TomB.51-55 
Acinetobacter baumannii, which is increasingly becoming 
a significant opportunistic pathogen in nosocomial 
infections, is a member of the Pseudomonadales order 
and Moraxellaceae family and has been observed to have 
the following systems: Maz EF; Hig BA; Rel BE; and also 
prevalent Che TA systems among their species Spl TA (or 
Abk AB), and Gra TA.56, 57
Chasing the Chance of the Presence of the RnlA-RnlB 
System in Other Members of Gammaproteobacteria 
Class
The system Rnl AB, which was reported in the E. coli 
K-12 strain MH1 by Koga et al in 2011,30 has not been 
reported in most of the articles on pathogenic bacteria. 
So, it is worth preparing a comprehensive insight into the 
probable chance of the presence of these proteins in the 
genome of important pathogenic bacteria, large numbers 
of them of which are present in Gammaproteobacteria, 
by bioinformatics tools. Because it is not always possible 
to record the functional information about particular 
domain functionality, it is important to pay attention to 
the sequences and bioinformatics annotations.58
The process started with finding RnlA and RnlB protein 
sequences in protein antra in the NCBI website (https://
www.ncbi.nlm.nih.gov). Among the results that were 
suggested by protein antra, the nearest one to the E. coli 
K-12 strain was CP4-57 prophage; RNase LS [E. coli str. 
K-12 sub.MG 1655], with 357 aa for RnlA; and CP4-
57 prophage, an uncharacterized protein [E. coli str. 
K-12 sub.MG 1655] with 123 aa, and these results are 
confirmed by the UniProt website (https://www.uniprot.
org),59 which contains a large amount of information 
about protein sequences and is freely accessible.
According to the NCBI Conserved Domain Database 
(CDD),60 which contains annotated biomolecular 
sequences with detailed information about their conserved 
domains, RnlA toxin possess 2 particular domains: DUF 
302 like superfamily (RNLA-N-1), with length of 227 aa 
(Pfam15935); and the second domain, RnlA toxin, which 
contains 99 aa (cd14794). The aim of considering the 
CCD database was to gain information on the sequence 
of these domains. Following that, a Psi-BLAST search 
was used for chasing these sequences between the 
members of Gammaproteobacteria (taxid:1236) using a 
non-redundant protein sequence database as target. By 
considering the query coverages higher than 90%, the 
Psi-BLAST was iterated 2 times for both the first and 
second domains of RnlA (RNLA-N-1). For RNLA-N-1 
domain, the number of psi-BLAST iterations was 2 times; 
for the second domain, this iteration was accomplished. 
Phylogenetic Tree Construction to Survey the Distribution 
of RnlA-RnlB Module Among Gammaproteobacteria 
Class
Then the results of PSI-BLAST were downloaded, and they 
were employed for the construction of the phylogenetic 
tree in Mega software version 7.61 The first step toward 
this was ClustalW algorithm was used to perform 
multiple sequence alignment. The aim of inferring the 
phylogenetic trees here was to screen the distribution of 
Rnl AB systems among class Gammaproteobacteria and 
to study the evolutionary relationships between their 
protein sequences. This, in turn, could help to determine 
the same possible functions for this system between 
other bacterial species. Although, among a broad range 
of TA modules present in bacterial genomes, only a few 
are really functional and experimental approaches are 
required for their functional characterization.
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Tree Depiction of Neighbor-Joining and Parsimony 
Method for Domains
Here, 2 kinds of phylogenic trees, neighbor-joining (NJ) 
and parsimony methods, were employed to deduce the 
phylogenetic trees. NJ is an agglomerative clustering 
method which is characterized as a progressive, distance-
based method. It can be applied to a large number of 
sequences (> 50). It should be mentioned that NJ generates 
an unrooted tree.
In maximum Parsimony method, the tree with the least 
number of changes is introduced as the most parsimonious 
tree, and as a result, this method is considered as one of 
the most precise approaches in inferring phylogenetic 
relationships. This method works with the “molecular 
clock” hypothesis, in which each family of proteins 
evolves with the constant rates of mutations. Figure 1 
represents the maximum parsimony tree of the RNLA-N-1 
superfamily of toxin RnlA. 
NJ and maximum parsimony trees for the RnlA-toxin 
superfamily (the second domain of RnlA toxin) and RnlB-
antitoxin superfamily illustrated as described here. Here, 
one of the trees which belongs to RNLA-N-1 domain-
(superfamily) distribution among Gammaproteobacteria 
members is depicted to show the process (Figure 1).62
The evolutionary history was inferred using the 
Neighbor-Joining method in MEGA7. The tree is drawn 
to scale, with branch lengths in the same units as those of 
the evolutionary distances used to infer the phylogenetic 
tree. The evolutionary distances were computed using the 
Poisson correction method (The Poisson correction for 
distance d assumes equal substitution rates across sites and 
equal amino acid frequencies. All positions containing 
gaps and missing data were eliminated. Evolutionary 
analyses were conducted in MEGA7.
Acinetobacter baumannii and Pseudomonas aeruginosa 
as 2 Problematic Pathogens
Owing to their presence in a broad range of nosocomial 
infections like burn wounds, these 2 pathogens have 
been remarkable choices to study. Here according to 
the presence of Rnl AB type II system domains in these 
pathogens, we mention that they may contain phage-
resistant systems, which are obstacles to T4 phage attack.
T4 Phage as a Weapon in Phage Therapy
T4-like phages have been used for therapeutic aims like 
phage therapy, which has been successful at least on a 
small scale. As for other therapeutic approaches, this 
procedure is not devoid of problems, and as mentioned in 
phage therapy articles, bacterial resistance may occur.63,64 
So, through knowledge of phage-resistant systems in 
important bacteria like A. baumannii and P. auroginosa, 
it is important to consider ways to prevent any problems.
Photodynamic Therapy as a Procedure for Weakening 
TA Systems for Better Results of Phage Therapy
Photodynamic therapy (PDT) is a therapeutic technique 
which utilizes photosensitizer (PS) dye and visible light. 
During this process, irradiation of a specific wavelength 
of visible light to the photosensitizer dye leads to reactive 
oxygen species (ROS) production.65,66 According to 
previous studies, it has been proved that PDT procedure 
has destructive effects on the expression of particular 
systems in bacterial cells. For example, reduction of pmrA/
Figure 1. Evolutionary Relationships of RNLA-N-1 Domain-(Superfamily) in Gammaproteobacteria Via Neighbor-Joining Phylogenetic Tree.
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pmrB 2-component signal system after PDT occurred in 
one study,67 and downregulation of biofilm-related genes 
(by conjugative PS) is another example of this effect.68 
Furthermore, there have been a number of experiments 
that have been worked on in preparation of a substrate 
which can be useful for another remedy. For example, 
blocking efflux pumps before PS incubation through PDT 
approach could help the process to be more effective,69 or 
deletion of genes which encode components of MexAB-
OprM efflux systems is useful for greater susceptibility 
of P. auroginosa for the PDT process (or using extracts 
to decrease expression of efflux pumps),70 or in another 
study, it was shown that the efflux pump inhibitor helps 
the disruption of E. fecalis biofilm by PDT.71 So, here 
we theorize that if the gene of the TA system which is 
responsible for phage resistance can be suppressed by 
ROS through the PDT process, it would be an appropriate 
substrate for phage therapy which is going to be used next.
Concluding Remarks
As described earlier, many TA systems have been 
introduced until now and some of them have been 
proved to be contributors to bacterial pathogenesis. The 
relationship between pathogenesis and these systems 
makes them an important study case for promoting new 
antibacterial targets in the future to use against bacterial 
infections, and the broad range of their distribution 
among important pathogenic bacteria reinforces the 
importance of their study. There have been a large number 
of studies which have focused on these systems and still 
more studies need to be done. Considering the important 
role of Rnl BA TA, and that the bioinformatics tools 
which have provided a background for studying more TA 
systems have not yet been reported, this study provides 
a compact report of distribution of Rnl BA TA domains 
among Gammaproteobacteria members, which can help 
in using this system in other pathogenic bacteria. Here, 
also the problem of phage resistance by equipping Rnl 
AB type II system has been discussed and suggested for 
utilization of PDT technique for the probable weakening 
of the mentioned system. By suppression of the phage-
resistance TA system, bacteria would no longer be able to 
show resistance to the phage, so one of the problems in 
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